William Lis

Insider Reports History

Entity
Individual
Location
Portola Pharmaceuticals, Inc., 270 East Grand Avenue, South San Francisco, CA
Signature
/s/ Bruce Blefeld, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by William Lis:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Zai Lab Ltd Director American Depositary Shares 53.1K $958K $18.04 Jul 1, 2024 Direct
Jasper Therapeutics, Inc. Director Voting Common Stock 53.5K $34.7K $0.65 Oct 13, 2023 Direct
Jasper Therapeutics, Inc. Director Stock Option (right to buy) 47K Jun 7, 2023 Direct

Insider Reports Filed by William Lis

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ZLAB Zai Lab Ltd Jul 1, 2024 2 -$180K 4 Jul 3, 2024 Director
ZLAB Zai Lab Ltd Jun 18, 2024 1 $0 4 Jun 20, 2024 Director
JSPR Jasper Therapeutics, Inc. Oct 13, 2023 1 -$6.78K 4 Oct 13, 2023 Director
ZLAB Zai Lab Ltd Jun 29, 2023 1 $500K 4 Jun 30, 2023 Director
JSPR Jasper Therapeutics, Inc. Jun 7, 2023 1 $0 4 Jun 8, 2023 Director
JSPR Jasper Therapeutics, Inc. Apr 13, 2023 1 -$12.2K 4 Apr 14, 2023 Director
ZLAB Zai Lab Ltd Mar 3, 2023 1 -$208K 4 Mar 7, 2023 Director
JSPR Jasper Therapeutics, Inc. Oct 12, 2022 1 $0 4 Oct 13, 2022 Director
JSPR Jasper Therapeutics, Inc. Jun 24, 2022 2 -$101K 4 Jun 28, 2022 Director
JSPR Jasper Therapeutics, Inc. Mar 21, 2022 4 $0 4 Mar 23, 2022 Executive Chairman of the Board, Director
ZLAB Zai Lab Ltd Jan 20, 2022 1 -$103K 4 Jan 21, 2022 Director
ZLAB Zai Lab Ltd Jan 3, 2022 1 $0 4 Jan 4, 2022 Director
ZLAB Zai Lab Ltd Dec 31, 2021 1 -$691K 5 Feb 14, 2022 Director
JSPR Jasper Therapeutics, Inc. Sep 24, 2021 0 $0 3 Oct 1, 2021 Chief Executive Officer, Director